Eventide Asset Management - Q4 2021 holdings

$7.83 Billion is the total value of Eventide Asset Management's 146 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 23.7% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A/Ssponsored adr$235,246,000
-15.6%
1,748,6480.0%3.01%
-18.2%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$225,319,000
+22.4%
1,635,000
+23.4%
2.88%
+18.6%
MTD  METTLER TOLEDO INTERNATIONAL$214,697,000
+23.2%
126,5000.0%2.74%
+19.4%
FIVN SellFIVE9 INC$200,899,000
-14.4%
1,463,000
-0.4%
2.57%
-17.0%
TTD SellTHE TRADE DESK INC$200,646,000
+3.5%
2,189,500
-20.6%
2.56%
+0.4%
IDXX  IDEXX LABS INC$185,488,000
+5.9%
281,7000.0%2.37%
+2.6%
DT BuyDYNATRACE INC$165,458,000
-14.8%
2,741,641
+0.1%
2.11%
-17.5%
ODFL  OLD DOMINION FREIGHT LINE IN$159,551,000
+25.3%
445,2000.0%2.04%
+21.4%
HUBS BuyHUBSPOT INC$158,613,000
-1.4%
240,633
+1.1%
2.03%
-4.4%
DLO BuyDLOCAL LTD$156,655,000
+468.5%
4,389,312
+769.1%
2.00%
+451.5%
ROP  ROPER TECHNOLOGIES INC$153,657,000
+10.3%
312,4000.0%1.96%
+6.8%
TT BuyTRANE TECHNOLOGIES PLC$148,128,000
+34.1%
733,200
+14.6%
1.89%
+29.9%
RXDX BuyPROMETHEUS BIOSCIENCES INC$145,120,000
+70.5%
3,742,507
+0.8%
1.85%
+65.1%
ARGX BuyARGENX SEsponsored adr$144,453,000
+43.6%
412,500
+23.9%
1.85%
+39.2%
NEP BuyNEXTERA ENERGY PARTNERS LP$140,492,000
+21.7%
1,664,600
+8.7%
1.80%
+17.9%
POOL SellPOOL CORP$139,859,000
+27.9%
247,100
-1.9%
1.79%
+23.9%
GLBE BuyGLOBAL E ONLINE LTD$135,647,000
+295.1%
2,139,886
+347.5%
1.73%
+282.6%
TREX BuyTREX CO INC$133,680,000
+48.7%
990,000
+12.2%
1.71%
+44.0%
ZI SellZOOMINFO TECHNOLOGIES INC$133,279,000
+2.7%
2,076,000
-2.1%
1.70%
-0.5%
LOW BuyLOWES COS INC$132,109,000
+28.3%
511,100
+0.7%
1.69%
+24.3%
LRCX SellLAM RESEARCH CORP$129,696,000
+11.5%
180,346
-11.8%
1.66%
+8.0%
GNRC BuyGENERAC HLDGS INC$129,542,000
+0.4%
368,100
+16.6%
1.66%
-2.8%
CTAS  CINTAS CORP$128,342,000
+16.4%
289,6000.0%1.64%
+12.8%
CRWD SellCROWDSTRIKE HLDGS INCcl a$125,942,000
-35.4%
615,100
-22.5%
1.61%
-37.4%
ASML SellASML HOLDING N V$122,844,000
-4.1%
154,300
-10.3%
1.57%
-7.1%
DHI BuyD R HORTON INC$116,215,000
+31.1%
1,071,600
+1.5%
1.48%
+27.0%
EXAS  EXACT SCIENCES CORP$115,967,000
-18.5%
1,490,0000.0%1.48%
-21.0%
WCN  WASTE CONNECTIONS INC$109,561,000
+8.2%
804,0000.0%1.40%
+4.9%
ENTG BuyENTEGRIS INC$99,708,000
+11.5%
719,500
+1.3%
1.27%
+8.1%
KRTX  KARUNA THERAPEUTICS INC$97,988,000
+7.1%
748,0000.0%1.25%
+3.7%
SPT BuySPROUT SOCIAL INC$90,322,000
-25.6%
995,943
+0.0%
1.15%
-28.0%
GH BuyGUARDANT HEALTH INC$88,628,000
+298.3%
886,100
+397.8%
1.13%
+286.7%
APTV  APTIV PLC$88,578,000
+10.7%
537,0000.0%1.13%
+7.3%
DDOG BuyDATADOG INC$87,096,000
+27.0%
489,000
+0.8%
1.11%
+23.1%
PANW  PALO ALTO NETWORKS INC$84,620,000
+16.2%
151,9870.0%1.08%
+12.6%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$76,907,000
+58.9%
1,263,471
+8.6%
0.98%
+54.1%
PRAX  PRAXIS PRECISION MEDICINES I$75,069,000
+6.5%
3,810,5990.0%0.96%
+3.2%
CCI BuyCROWN CASTLE INTL CORP NEW$69,552,000
+22.5%
333,200
+1.7%
0.89%
+18.7%
YETI BuyYETI HLDGS INC$66,504,000
+12.5%
802,900
+16.4%
0.85%
+9.0%
KNBE NewKNOWBE4 INCcl a$66,205,0002,886,000
+100.0%
0.85%
W  WAYFAIR INCcl a$63,541,000
-25.6%
334,4770.0%0.81%
-28.0%
MGA SellMAGNA INTL INC$61,871,000
+5.4%
764,400
-2.0%
0.79%
+2.2%
A BuyAGILENT TECHNOLOGIES INC$60,076,000
+18.3%
376,300
+16.8%
0.77%
+14.6%
HASI BuyHANNON ARMSTRONG SUST INFR C$56,902,000
+10.4%
1,071,200
+11.1%
0.73%
+6.9%
NRIX BuyNURIX THERAPEUTICS INC$54,137,000
+50.6%
1,870,000
+55.8%
0.69%
+46.0%
CWEN BuyCLEARWAY ENERGY INCcl c$53,440,000
+25.9%
1,483,200
+5.7%
0.68%
+22.0%
VITL  VITAL FARMS INC$53,277,000
+2.8%
2,950,0000.0%0.68%
-0.3%
SMAR BuySMARTSHEET INC$52,511,000
+14.9%
678,000
+2.1%
0.67%
+11.3%
NOVT  NOVANTA INC$49,372,000
+14.1%
280,0000.0%0.63%
+10.7%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$49,327,000
-2.5%
410,000
-9.5%
0.63%
-5.5%
COLL  COLLEGIUM PHARMACEUTICAL INC$49,121,000
-5.4%
2,629,5930.0%0.63%
-8.2%
XMTR BuyXOMETRY INC$48,894,000
+14.1%
954,030
+28.4%
0.62%
+10.6%
VRSK  VERISK ANALYTICS INC$48,719,000
+14.2%
213,0000.0%0.62%
+10.7%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$47,871,000
-21.4%
1,238,900
+9.8%
0.61%
-23.8%
MDB  MONGODB INCcl a$47,300,000
+12.3%
89,3550.0%0.60%
+8.6%
EPIX BuyESSA PHARMA INC$47,125,000
+170.1%
3,318,647
+52.2%
0.60%
+161.7%
ZYME SellZYMEWORKS INC$46,206,000
-57.3%
2,819,135
-24.4%
0.59%
-58.7%
 DICE THERAPEUTICS INC$45,761,000
-22.7%
1,871,6120.0%0.58%
-25.1%
SHLS SellSHOALS TECHNOLOGIES GROUP INcl a$44,880,000
-15.5%
1,846,900
-3.1%
0.57%
-18.1%
ZNTL  ZENTALIS PHARMACEUTICALS INC$44,468,000
+26.1%
529,0000.0%0.57%
+22.2%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$44,236,000
-3.0%
1,236,0000.0%0.56%
-6.1%
MRTX BuyMIRATI THERAPEUTICS INC$42,779,000
+86.8%
291,626
+125.2%
0.55%
+81.1%
COUR BuyCOURSERA INC$42,482,000
+67.8%
1,738,228
+117.3%
0.54%
+62.6%
BPMC BuyBLUEPRINT MEDICINES CORP$42,394,000
+15.8%
395,800
+11.2%
0.54%
+12.2%
IMVT  IMMUNOVANT INC$42,174,000
-2.0%
4,950,0000.0%0.54%
-4.9%
MPWR BuyMONOLITHIC PWR SYS INC$42,011,000
+11.9%
85,157
+9.9%
0.54%
+8.5%
STRO BuySUTRO BIOPHARMA INC$40,310,000
-10.0%
2,708,975
+14.3%
0.52%
-12.9%
ADCT BuyADC THERAPEUTICS SA$39,895,000
+12.0%
1,975,000
+50.5%
0.51%
+8.5%
CCXI  CHEMOCENTRYX INC$37,866,000
+112.9%
1,040,0000.0%0.48%
+106.0%
NCNO BuyNCINO INC$37,744,000
-19.8%
688,000
+3.8%
0.48%
-22.4%
MASS Buy908 DEVICES INC$36,477,000
+64.4%
1,410,000
+106.7%
0.47%
+59.0%
LSCC BuyLATTICE SEMICONDUCTOR CORP$36,353,000
+862.0%
471,744
+707.1%
0.46%
+830.0%
ANNX BuyANNEXON INC$32,747,000
-30.5%
2,850,000
+12.6%
0.42%
-32.7%
NVT BuyNVENT ELECTRIC PLC$31,624,000
+26.7%
832,200
+7.8%
0.40%
+22.8%
RGEN  REPLIGEN CORP$31,516,000
-8.4%
119,0000.0%0.40%
-11.0%
COGT NewCOGENT BIOSCIENCES INC$30,158,0003,514,909
+100.0%
0.38%
BEPC SellBROOKFIELD RENEWABLE CORPcl a sub vtg$28,544,000
-19.7%
775,019
-15.4%
0.36%
-22.2%
CGNX  COGNEX CORP$27,916,000
-3.1%
359,0000.0%0.36%
-6.1%
NewDUOLINGO INC$27,323,000257,500
+100.0%
0.35%
PLD BuyPROLOGIS INC.$27,039,000
+47.2%
160,600
+9.6%
0.35%
+43.0%
ISRG BuyINTUITIVE SURGICAL INC$26,948,000
+8.4%
75,000
+200.0%
0.34%
+4.9%
VCYT  VERACYTE INC$26,821,000
-11.3%
651,0000.0%0.34%
-14.0%
SNDX  SYNDAX PHARMACEUTICALS INC$25,502,000
+14.5%
1,165,0000.0%0.33%
+10.9%
KLAC SellKLA CORP$24,528,000
+19.4%
57,028
-7.1%
0.31%
+15.5%
REXR BuyREXFORD INDL RLTY INC$23,958,000
+125.0%
295,374
+57.4%
0.31%
+118.6%
PNR BuyPENTAIR PLC$23,866,000
+37.4%
326,800
+36.6%
0.30%
+33.2%
CIEN SellCIENA CORP$23,861,000
+41.8%
310,000
-5.4%
0.30%
+37.4%
TALS  TALARIS THERAPEUTICS INC$23,869,000
+15.4%
1,561,0920.0%0.30%
+11.7%
STE SellSTERIS PLC$23,851,000
+15.0%
97,985
-3.5%
0.30%
+11.7%
LOB BuyLIVE OAK BANCSHARES INC$23,230,000
+41.0%
266,128
+2.8%
0.30%
+36.9%
ESI BuyELEMENT SOLUTIONS INC$22,670,000
+123.4%
933,700
+99.5%
0.29%
+116.4%
NDAQ BuyNASDAQ INC$22,261,000
+33.9%
106,000
+23.1%
0.28%
+29.7%
CGEM  CULLINAN ONCOLOGY INC$21,665,000
-31.6%
1,440,1450.0%0.28%
-33.7%
XNCR  XENCOR INC$20,301,000
+22.8%
506,0000.0%0.26%
+18.8%
NBIX  NEUROCRINE BIOSCIENCES INC$20,015,000
-11.2%
235,0000.0%0.26%
-13.8%
ELS BuyEQUITY LIFESTYLE PPTYS INC$20,004,000
+30.1%
228,200
+16.0%
0.26%
+26.1%
 GXO LOGISTICS INCORPORATED$19,983,000
+15.8%
220,0000.0%0.26%
+11.8%
FRC SellFIRST REP BK SAN FRANCISCO C$19,598,000
+3.0%
94,900
-3.8%
0.25%
-0.4%
KURA  KURA ONCOLOGY INC$19,055,000
-25.3%
1,361,0440.0%0.24%
-27.7%
SNV BuySYNOVUS FINL CORP$18,382,000
+189.3%
384,000
+165.2%
0.24%
+179.8%
XPO  XPO LOGISTICS INC$17,035,000
-2.7%
220,0000.0%0.22%
-5.6%
MAX  MEDIAALPHA INCcl a$16,957,000
-17.3%
1,098,2460.0%0.22%
-19.9%
SNPS  SYNOPSYS INC$16,861,000
+23.1%
45,7570.0%0.22%
+18.8%
APTVPRA NewAPTIV PLC5.5% cnv pfd a added$16,098,00087,500
+100.0%
0.21%
SBNY SellSIGNATURE BK NEW YORK N Y$15,769,000
+15.1%
48,750
-3.1%
0.20%
+11.6%
SellPALO ALTO NETWORKS INCnote 0.750% 7/0$14,293,000
-20.3%
6,810,000
-30.9%
0.18%
-22.8%
IEX BuyIDEX CORP$13,801,000
+45.9%
58,400
+27.8%
0.18%
+40.8%
ENPH NewENPHASE ENERGY INC$12,166,00066,500
+100.0%
0.16%
AESC  AES CORPunit 99/99/9999$11,866,000
-0.4%
123,6000.0%0.15%
-3.2%
VECT  VECTIVBIO HLDG AG$11,186,000
-36.4%
2,339,0440.0%0.14%
-38.4%
SYY BuySYSCO CORP$10,321,000
+45.6%
131,398
+45.5%
0.13%
+41.9%
COMP SellCOMPASS INCcl a$10,098,000
-75.2%
1,110,899
-63.8%
0.13%
-75.9%
CRDF  CARDIFF ONCOLOGY INC$10,039,000
-9.8%
1,670,3990.0%0.13%
-12.9%
ETNB Sell89BIO INC$9,367,000
-58.0%
716,670
-37.0%
0.12%
-59.2%
DSGN  DESIGN THERAPEUTICS INC$8,564,000
+45.7%
400,0000.0%0.11%
+41.6%
GRMN BuyGARMIN LTD$8,306,000
+19.0%
61,000
+35.9%
0.11%
+15.2%
WMS  ADVANCED DRAIN SYS INC DEL$7,906,000
+25.9%
58,0780.0%0.10%
+21.7%
WMB NewWILLIAMS COS INC$7,523,000288,900
+100.0%
0.10%
IMGN NewIMMUNOGEN INC$7,420,0001,000,000
+100.0%
0.10%
BOLT BuyBOLT BIOTHERAPEUTICS INC$7,103,000
+5.2%
1,449,494
+171.4%
0.09%
+2.2%
EGP NewEASTGROUP PPTYS INC$6,881,00030,200
+100.0%
0.09%
NewROIVANT SCIENCES LTD$6,703,000700,000
+100.0%
0.09%
FRLN  FREELINE THERAPEUTICS HLDGSsponsored ads$6,746,000
-42.7%
3,485,6560.0%0.09%
-44.5%
PHAT SellPHATHOM PHARMACEUTICALS INC$6,614,000
-65.7%
336,223
-44.0%
0.08%
-66.5%
LNG NewCHENIERE ENERGY INC$6,684,00065,900
+100.0%
0.08%
AQNU  ALGONQUIN PWR UTILS CORPunit 99/99/9999$6,651,000
-2.4%
140,8000.0%0.08%
-5.6%
BRKS NewAZENTA INC$6,589,00063,900
+100.0%
0.08%
SHW SellSHERWIN WILLIAMS CO$6,515,000
-11.8%
18,500
-29.9%
0.08%
-14.4%
AWK  AMERICAN WTR WKS CO INC NEW$6,440,000
+11.7%
34,1000.0%0.08%
+7.9%
KBH  KB HOME$6,338,000
+14.9%
141,7000.0%0.08%
+11.0%
ICPT NewINTERCEPT PHARMACEUTICALS IN$5,334,000327,444
+100.0%
0.07%
SBAC SellSBA COMMUNICATIONS CORP NEWcl a$5,135,000
-34.7%
13,200
-44.5%
0.07%
-36.5%
FOUR BuySHIFT4 PMTS INCcl a$5,156,000
+34.1%
89,000
+79.4%
0.07%
+29.4%
ARE SellALEXANDRIA REAL ESTATE EQ IN$4,749,000
-7.3%
21,300
-20.5%
0.06%
-10.3%
NEE  NEXTERA ENERGY INC$4,472,000
+18.9%
47,9000.0%0.06%
+14.0%
PHVS  PHARVARIS N V$3,875,000
-8.3%
244,9250.0%0.05%
-10.7%
SLAB  SILICON LABORATORIES INC$3,950,000
+47.3%
19,1370.0%0.05%
+42.9%
NewARTERIS INC$3,805,000180,259
+100.0%
0.05%
 EXACT SCIENCES CORPnote 0.375% 3/0$3,703,000
-10.0%
3,815,0000.0%0.05%
-13.0%
OM BuyOUTSET MED INC$3,180,000
-0.1%
69,000
+7.1%
0.04%
-2.4%
NewGUARDANT HEALTH INCnote 11/1$2,948,0002,900,000
+100.0%
0.04%
KALV SellKALVISTA PHARMACEUTICALS INC$1,837,000
-84.2%
138,821
-79.1%
0.02%
-85.0%
ETTX  ENTASIS THERAPEUTICS HLDGS I$1,293,000
-34.5%
590,6020.0%0.02%
-34.6%
NewPLANET LABS PBC$953,000155,000
+100.0%
0.01%
ALLK SellALLAKOS INC$882,000
-98.7%
90,084
-85.7%
0.01%
-98.8%
PLRX SellPLIANT THERAPEUTICS INC$574,000
-98.4%
42,499
-98.1%
0.01%
-98.6%
DOCU ExitDOCUSIGN INC$0-4,819
-100.0%
-0.02%
PATH ExitUIPATH INCcl a$0-39,000
-100.0%
-0.03%
RPM ExitRPM INTL INC$0-28,200
-100.0%
-0.03%
TMDX ExitTRANSMEDICS GROUP INC$0-77,364
-100.0%
-0.03%
JKHY ExitHENRY JACK & ASSOC INC$0-19,600
-100.0%
-0.04%
ZTS ExitZOETIS INCcl a$0-19,900
-100.0%
-0.05%
VFC ExitV F CORP$0-77,300
-100.0%
-0.07%
FHN ExitFIRST HORIZON CORPORATION$0-377,600
-100.0%
-0.08%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-400,000
-100.0%
-0.18%
ORIC ExitORIC PHARMACEUTICALS INC$0-724,972
-100.0%
-0.20%
BYND ExitBEYOND MEAT INC$0-152,593
-100.0%
-0.21%
BFLY ExitBUTTERFLY NETWORK INC$0-1,776,000
-100.0%
-0.24%
FIVN ExitFIVE9 INCcall$0-108,800
-100.0%
-0.26%
SWKS ExitSKYWORKS SOLUTIONS INC$0-150,047
-100.0%
-0.33%
ROL ExitROLLINS INC$0-727,500
-100.0%
-0.34%
LII ExitLENNOX INTL INC$0-95,000
-100.0%
-0.37%
RNG ExitRINGCENTRAL INCcl a$0-147,308
-100.0%
-0.42%
TPTX ExitTURNING POINT THERAPEUTICS I$0-578,000
-100.0%
-0.51%
ExitTRILLIUM THERAPEUTICS INC$0-5,227,376
-100.0%
-1.21%
TWLO ExitTWILIO INCcl a$0-393,490
-100.0%
-1.66%
FVRR ExitFIVERR INTL LTD$0-696,962
-100.0%
-1.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC43Q2 20243.2%
PALO ALTO NETWORKS INC43Q2 20243.6%
ASML HOLDINGS NV43Q2 20241.9%
REPLIGEN CORP43Q2 20240.5%
VERACYTE INC41Q2 20241.5%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
LAM RESEARCH CORP38Q2 20243.4%
COLLEGIUM PHARMACEUTICAL INC37Q2 20242.6%
BLUEPRINT MEDICINES CORP36Q2 20241.3%
XPO LOGISTICS INC34Q1 20233.8%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
908 Devices Inc.February 14, 20241,430,9954.4%
Annexon, Inc.Sold outFebruary 14, 202400.0%
Celldex Therapeutics, Inc.February 14, 20243,630,0136.6%
COLLEGIUM PHARMACEUTICAL, INCFebruary 14, 20242,630,4788.1%
Freeline Therapeutics Holdings plcSold outFebruary 14, 202400.0%
Inozyme Pharma, Inc.February 14, 20243,179,8375.2%
Korro Bio, Inc.February 14, 2024546,3256.8%
MARINUS PHARMACEUTICALS, INC.February 14, 20244,529,9978.3%
Mirum Pharmaceuticals, Inc.February 14, 20242,693,5815.8%
Praxis Precision Medicines, Inc.Sold outFebruary 14, 202400.0%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
SC 13G/A2024-08-09
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings